Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
filingDate |
2004-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2006-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2006519616-A |
titleOfInvention |
Tyrosine phosphatase-PRL-1, marker for pancreatic cancer and therapeutic target |
abstract |
Using gene expression profiling, the present invention identifies tyrosine phosphatase IVA member 1 (PRL-1) as a diagnostic marker and therapeutic target for pancreatic cancer. Accordingly, the present invention provides methods for predicting and detecting cancers associated with PRL-1, and methods for evaluating PRL-1 inhibitors. The present invention also provides a method for treating or preventing pancreatic cancer in a subject. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7330235-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012517453-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017503488-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021168674-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113088554-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020022469-A |
priorityDate |
2003-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |